Akèy › Maladi Nèwolojik › North Carolina
Etid klinik pou Maladi Nèwolojik nan North Carolina
7 etid pou Maladi Nèwolojik ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Denver, North Carolina, Denver
- Huntersville, North Carolina, Huntersville
Ap rekriteFaz 2/3
Laj 18 a 70 · Tout sèks · Mizajou Oct 2, 2026 · NCT07598708Product Surveillance Registry
- Chapel Hill
- Charleston
- Durham
- ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Chapel Hill
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 15, 2026 · NCT06916806A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #067, Raleigh
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Duke University, Durham
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590Rett Syndrome Registry
- The University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteEtid obsèvasyon
Laj 0 a 99 · Tout sèks · Mizajou Jun 30, 2026 · NCT05432349Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Matthews
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.